(XIEE) db x-trackers MSCI Europe - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1242369327 • Europe Large-Cap Blend Equity
XIEE: Stocks, European, Equities, Investments
DB X-Trackers MSCI Europe UCITS DR 1D, traded under the ticker XIEE on XETRA, is a Germany-originated ETF designed to track the performance of large-cap companies across Europe. Managed by DWS, a well-established asset management firm, this fund is structured as a UCITS (Undertakings for the Collective Investment in Transferable Securities), which is a regulated investment scheme originating in the European Union. UCITS funds are known for their strict regulatory oversight, liquidity, and transparency, making them a preferred choice for many investors.
The fund is domiciled in Luxembourg, a common choice for European ETFs due to its favorable regulatory environment and tax-efficient structure. It seeks to replicate the performance of the Morningstar Developed Europe Target Market Exposure Net Return EUR Index, which is designed to capture the equity market performance of large-cap companies in developed European markets. The index includes a diverse range of sectors and companies, providing broad exposure to the European economy.
With an AUM (Assets Under Management) of approximately 4.687 billion EUR, this ETF is considered a large and liquid fund, which typically translates to tighter bid-ask spreads and lower trading costs for investors. The fund’s size also suggests a diversified portfolio, as it tracks a broad market index rather than focusing on a specific sector or theme. This diversification can reduce risk for investors seeking exposure to European equities without taking on excessive concentration risk.
For investors and fund managers, it’s important to note that this ETF does not currently report key valuation metrics such as P/E, P/B, or P/S ratios. This is not uncommon for index-tracking ETFs, as their performance is primarily driven by the underlying index rather than individual stock selection. However, the fund’s structure and tracking methodology are critical factors to evaluate when assessing its suitability for a portfolio.
For more detailed information about the fund, including its full holdings, expense ratio, and historical performance, investors can visit the DWS website at http://www.dws.lu.
Additional Sources for XIEE ETF
XIEE ETF Overview
Market Cap in USD | 4,923m |
Category | Europe Large-Cap Blend Equity |
TER | 0.12% |
IPO / Inception | 2015-09-30 |
XIEE ETF Ratings
Growth 5y | 62.8% |
Fundamental | - |
Dividend | 29.3% |
Rel. Strength Industry | 5.51 |
Analysts | - |
Fair Price Momentum | 74.87 EUR |
Fair Price DCF | - |
XIEE Dividends
Dividend Yield 12m | 2.44% |
Yield on Cost 5y | 3.58% |
Annual Growth 5y | 1.60% |
Payout Consistency | 61.9% |
XIEE Growth Ratios
Growth Correlation 3m | 80.3% |
Growth Correlation 12m | 63.1% |
Growth Correlation 5y | 91.2% |
CAGR 5y | 9.04% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | 1.06 |
Alpha | 4.19 |
Beta | 0.50 |
Volatility | 9.80% |
Current Volume | 0k |
Average Volume 20d | 1.5k |
As of February 22, 2025, the stock is trading at EUR 77.62 with a total of 1 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +4.20%, over three months by +9.37% and over the past year by +14.60%.
Yes. Based on ValueRay Analyses, db x-trackers MSCI Europe (XETRA:XIEE) is currently (February 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.83 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XIEE as of February 2025 is 74.87. This means that XIEE is currently overvalued and has a potential downside of -3.54%.
db x-trackers MSCI Europe has no consensus analysts rating.
According to ValueRays Forecast Model, XIEE db x-trackers MSCI Europe will be worth about 86.2 in February 2026. The stock is currently trading at 77.62. This means that the stock has a potential upside of +11.08%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 86.2 | 11.1% |